Kesin launches first FDA-approved specialty brand

Kesin is committed to developing a portfolio of strategic NDA505(b)(2) brand products to materially impact patient outcomes and access. Our technology-driven solutions support increased convenience, effectiveness, and persistence.

Kesin is working to maximize efficiency, reduce costs, and impact patient outcomes with our unit-dose packaged offerings. Our high-quality pharmaceutical repackaging solutions promote enhanced patient accessibility, adherence, and safety.

Our leadership operates within an ecosystem designed to pursue one goal: prioritizing patients.